AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 1.695
-0.025 (-1.45%)
Mar 20, 2026, 5:22 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 197.65 million as of March 20, 2026. Its market cap has increased by 1.29% in one year.
Market Cap
197.65M
Enterprise Value
149.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 197.65M, a decrease of -52.42%. That is a compound annual growth rate of -9.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 197.65M | -14.00% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipum AB | 302.28M |
| Elicera Therapeutics AB | 257.24M |
| Mendus AB | 254.29M |
| Intervacc AB | 252.20M |
| Sprint Bioscience AB | 215.25M |
| Initiator Pharma | 212.20M |
| Xintela AB | 204.98M |
| Isofol Medical AB | 185.11M |